AL-15469A for the Treatment of Bacterial Conjunctivitis
NCT00331916
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Conjunctivitis
Interventions
DRUG:
quinolone
Sponsor
Alcon Research